RuiPai Medical Submits IPO Prospectus Highlighting Its Integrated Solution for Disposable Electronic Cystoscopes

Disposable endoscopes can reduce hospitals’ initial procurement costs as well as operational and maintenance expenses, facilitating the adoption of minimally invasive procedures at primary-care hospitals and lowering patients’ medical costs associated with seeking care in distant locations. Furthermore, disposable endoscopes come in sterile packaging and do not require reprocessing or sterilization, thereby streamlining turnover between consecutive surgeries, improving efficiency, enabling hospitals to serve more patients, shortening wait times for patients at tertiary (Grade III) hospitals, and alleviating the burden on patients traveling from other regions to some extent.

Ruipai Medical holds China’s Class III certification for domestically produced single-use endoscopes.Medical Device Registration CertificateThe largest manufacturer.

August 16 (Wednesday) at 19:30, VCBeat Select New Product Review Session No. 24, featuringCindy, Urology Product Promotion Manager at Ruipai MedicalSharing of the Total Solution for Disposable Electronic Cystoscopy.

· Single-use, reducing the risk of cross-infection.

· Reduce hospitals' initial procurement costs and facilitate the adoption of surgical procedures.

· No disinfection or sterilization is required, eliminating the need for dedicated personnel and associated costs, as well as maintenance expenses.

· Consecutive surgeries are more convenient, improving efficiency.

· Slim or Soft Disposable Cystoscopes Significantly Reduce Patient Pain

Scan the QR code on the poster to add our assistant and reserve your spot for the live stream!

Ruipai Medical, established in 2015, is a national high-tech enterprise dedicated to the R&D, manufacturing, and sales of single-use endoscopes. Its product portfolio includes single-use endoscopes, medical endoscopic image processors, and single-use therapeutic instruments for endoscopic procedures.

After years of dedicated development, Ruipai Medical has established robust barriers to entry in R&D, manufacturing, supply chain, and commercialization. In recent years, as its globalization efforts have accelerated, Ruipai Medical is rapidly advancing toward becoming a globally leading platform for single-use endoscopes, enabling patients worldwide to access affordable, high-quality medical resources made in China.

“Artery Select New Product Debut” is a live-streaming series under “Artery Select” designed to support medical enterprises in launching innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product.

Scan the QR code to reserve your spot for the live broadcast